Cargando…

Elevated serum IFN-γand IFN-γ/IL-6 ratio in Kikuchi-Fujimoto disease

BACKGROUND: Kikuchi-Fujimoto disease (KFD) is typically a benign, self-limiting inflammatory disease. The diagnosis of KFD can be challenging for nonspecific symptoms, laboratory or imaging findings. In this study, we aimed to describe the clinical manifestations of patients with KFD and to access t...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Tingyan, Shen, Zixuan, Ling, Jiayun, Zhu, Xiaona, Yang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463342/
https://www.ncbi.nlm.nih.gov/pubmed/37608293
http://dx.doi.org/10.1186/s12969-023-00877-w
_version_ 1785098208620314624
author He, Tingyan
Shen, Zixuan
Ling, Jiayun
Zhu, Xiaona
Yang, Jun
author_facet He, Tingyan
Shen, Zixuan
Ling, Jiayun
Zhu, Xiaona
Yang, Jun
author_sort He, Tingyan
collection PubMed
description BACKGROUND: Kikuchi-Fujimoto disease (KFD) is typically a benign, self-limiting inflammatory disease. The diagnosis of KFD can be challenging for nonspecific symptoms, laboratory or imaging findings. In this study, we aimed to describe the clinical manifestations of patients with KFD and to access the potential role of serum cytokines in the diagnosis of this disease. METHODS: Patients with KFD were retrospectively enrolled from January 2015 to November 2021 at Shenzhen Children’s Hospital. Clinical data were collected from inpatient or outpatient medical records. Serum cytokines were detected by the Flowcytomix technique. Serum levels of cytokines were compared between patients with KFD and SJIA, or patients with KFD and KD. The data of patients without MAS were further analyzed. A receiver operating characteristic (ROC) curve analysis was further performed to access the potential role of serum cytokines in the diagnosis of KFD. RESULTS: Serum cytokines were detected in 25 (43.8%, 25/57) patients with a histological diagnosis of KFD. Compared to SJIA or KD patients, the KFD group had a significantly higher IFN-γ/IL-6 ratio and much lower levels of serum IL-6. The median level of serum IFN-γ in KFD was 41.65 pg/ml (range, 21.04–70.74 pg/ml), which was much higher than that in SJIA (median: 3.33 pg/ml, p = 0.16) or KD (median: 2.6 pg/ml, p = 0.01). After excluding patients with MAS, there was statistical significance in all comparisons of serum IFN-γ, IFN-γ/IL-6 ratio, and serum IL-6. The cutoff values of serum IFN-γ, IL-6, and IFN-γ/IL-6 ratio for differentiating KFD from SJIA were > 8.48 pg/ml, < 47.42 pg/ml, and > 0.45, respectively. The cutoff values of serum IFN-γ, IL-6, and IFN-γ/IL-6 ratio for differentiating KFD from KD were > 8.56 pg/ml, < 50.45 pg/ml, and > 0.45, respectively. The specificity of all those cutoff values for differentiating KFD from SJIA or KD was ≥ 94.7%. CONCLUSIONS: For patients with fever of unknown etiology and lymphadenopathy, after excluding HLH or MAS, serum IFN-γ > 8.56 pg/mL and IFN-γ/IL-6 ratio > 0.45 may highly suggest the diagnosis of KFD; serum IL-6 > 50.45 pg/mL indicates that the probability of KFD may be small, and sJIA, KD, and acute infection should be excluded first. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12969-023-00877-w.
format Online
Article
Text
id pubmed-10463342
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104633422023-08-30 Elevated serum IFN-γand IFN-γ/IL-6 ratio in Kikuchi-Fujimoto disease He, Tingyan Shen, Zixuan Ling, Jiayun Zhu, Xiaona Yang, Jun Pediatr Rheumatol Online J Research Article BACKGROUND: Kikuchi-Fujimoto disease (KFD) is typically a benign, self-limiting inflammatory disease. The diagnosis of KFD can be challenging for nonspecific symptoms, laboratory or imaging findings. In this study, we aimed to describe the clinical manifestations of patients with KFD and to access the potential role of serum cytokines in the diagnosis of this disease. METHODS: Patients with KFD were retrospectively enrolled from January 2015 to November 2021 at Shenzhen Children’s Hospital. Clinical data were collected from inpatient or outpatient medical records. Serum cytokines were detected by the Flowcytomix technique. Serum levels of cytokines were compared between patients with KFD and SJIA, or patients with KFD and KD. The data of patients without MAS were further analyzed. A receiver operating characteristic (ROC) curve analysis was further performed to access the potential role of serum cytokines in the diagnosis of KFD. RESULTS: Serum cytokines were detected in 25 (43.8%, 25/57) patients with a histological diagnosis of KFD. Compared to SJIA or KD patients, the KFD group had a significantly higher IFN-γ/IL-6 ratio and much lower levels of serum IL-6. The median level of serum IFN-γ in KFD was 41.65 pg/ml (range, 21.04–70.74 pg/ml), which was much higher than that in SJIA (median: 3.33 pg/ml, p = 0.16) or KD (median: 2.6 pg/ml, p = 0.01). After excluding patients with MAS, there was statistical significance in all comparisons of serum IFN-γ, IFN-γ/IL-6 ratio, and serum IL-6. The cutoff values of serum IFN-γ, IL-6, and IFN-γ/IL-6 ratio for differentiating KFD from SJIA were > 8.48 pg/ml, < 47.42 pg/ml, and > 0.45, respectively. The cutoff values of serum IFN-γ, IL-6, and IFN-γ/IL-6 ratio for differentiating KFD from KD were > 8.56 pg/ml, < 50.45 pg/ml, and > 0.45, respectively. The specificity of all those cutoff values for differentiating KFD from SJIA or KD was ≥ 94.7%. CONCLUSIONS: For patients with fever of unknown etiology and lymphadenopathy, after excluding HLH or MAS, serum IFN-γ > 8.56 pg/mL and IFN-γ/IL-6 ratio > 0.45 may highly suggest the diagnosis of KFD; serum IL-6 > 50.45 pg/mL indicates that the probability of KFD may be small, and sJIA, KD, and acute infection should be excluded first. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12969-023-00877-w. BioMed Central 2023-08-22 /pmc/articles/PMC10463342/ /pubmed/37608293 http://dx.doi.org/10.1186/s12969-023-00877-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
He, Tingyan
Shen, Zixuan
Ling, Jiayun
Zhu, Xiaona
Yang, Jun
Elevated serum IFN-γand IFN-γ/IL-6 ratio in Kikuchi-Fujimoto disease
title Elevated serum IFN-γand IFN-γ/IL-6 ratio in Kikuchi-Fujimoto disease
title_full Elevated serum IFN-γand IFN-γ/IL-6 ratio in Kikuchi-Fujimoto disease
title_fullStr Elevated serum IFN-γand IFN-γ/IL-6 ratio in Kikuchi-Fujimoto disease
title_full_unstemmed Elevated serum IFN-γand IFN-γ/IL-6 ratio in Kikuchi-Fujimoto disease
title_short Elevated serum IFN-γand IFN-γ/IL-6 ratio in Kikuchi-Fujimoto disease
title_sort elevated serum ifn-γand ifn-γ/il-6 ratio in kikuchi-fujimoto disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463342/
https://www.ncbi.nlm.nih.gov/pubmed/37608293
http://dx.doi.org/10.1186/s12969-023-00877-w
work_keys_str_mv AT hetingyan elevatedserumifngandifngil6ratioinkikuchifujimotodisease
AT shenzixuan elevatedserumifngandifngil6ratioinkikuchifujimotodisease
AT lingjiayun elevatedserumifngandifngil6ratioinkikuchifujimotodisease
AT zhuxiaona elevatedserumifngandifngil6ratioinkikuchifujimotodisease
AT yangjun elevatedserumifngandifngil6ratioinkikuchifujimotodisease